{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:44:11Z","timestamp":1791387851260,"version":"4.3.3"},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1786,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1478-3231.2010.02346.x","type":"journal-article","created":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T10:50:21Z","timestamp":1286794221000},"page":"348-353","source":"Crossref","is-referenced-by-count":65,"title":["Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease"],"prefix":"10.1111","volume":"31","author":[{"given":"Paulo Adriano","family":"Schwingel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helma P.","family":"Cotrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo Rios","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Crim\u00e9rio Ribeiro","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Nachef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Ricardo","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio C.","family":"Zoppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,11]]},"reference":[{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.coph.2004.05.006","article-title":"Abuse of anabolic androgenic steroids and related substances in sport and exercise","volume":"4","author":"Bahrke","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB2|cit2","first-page":"908","article-title":"Anabolic steroid usage in athletics","author":"Berning","year":"2004","journal-title":"facts, fiction, and public relations"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0363546503262202","article-title":"Current concepts in anabolic-androgenic steroids","volume":"32","author":"Evans","year":"2004","journal-title":"Am J Sports Med"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB4|cit4","volume-title":"II Household Survey on the Use of Psychotropic Drugs in Brazil: 2005","author":"Carlini","year":"2007"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1478-3231.2007.01579.x","article-title":"Anabolic-androgenic steroids and liver injury","volume":"28","author":"Sanchez-Osorio","year":"2008","journal-title":"Liver Int"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB7|cit7","first-page":"1413","article-title":"Nonalcoholic fatty liver disease","volume":"116","author":"Matteoni","year":"1999","journal-title":"a spectrum of clinical and pathological severity"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.mco.0000241677.40170.17","article-title":"Non-alcoholic steatohepatitis and metabolic syndrome","volume":"9","author":"Machado","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1478-3231.2004.0897.x","article-title":"Clinical and histopathological features of NASH in workers exposed to chemicals with or without associated metabolic conditions","volume":"24","author":"Cotrim","year":"2004","journal-title":"Liver Int"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.23321","article-title":"Toxicant-associated steatohepatitis in vinyl chloride workers","volume":"51","author":"Cave","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5694\/j.1326-5377.1999.tb139171.x","article-title":"New classification and criteria for diagnosis of diabetes mellitus. Position Statement from the Australian Diabetes Society, New Zealand Society for the Study of Diabetes, Royal College of Pathologists of Australasia and Australasian Association of Clinical Biochemists","volume":"170","author":"Colman","year":"1999","journal-title":"Med J Aust"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1079\/BJN19780152","article-title":"Generalized equations for predicting body density of men","volume":"40","author":"Jackson","year":"1978","journal-title":"Br J Nutr"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00005768-199901000-00008","article-title":"Prescription of resistance training for health and disease","volume":"31","author":"Feigenbaum","year":"1999","journal-title":"Med Sci Sports Exerc"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB14|cit14","first-page":"837","article-title":"Non-alcoholic fatty liver disease and insulin resistance","volume":"17","author":"Guidorizzi de Siqueira","year":"2005","journal-title":"importance of risk factors and histological spectrum"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cld.2007.02.014","article-title":"Role of radiologic modalities in the management of non-alcoholic steatohepatitis","volume":"11","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.CSMR.0000306529.74500.f6","article-title":"The effect of anabolic steroids on the gastrointestinal system, kidneys, and adrenal glands","volume":"5","author":"Modlinski","year":"2006","journal-title":"Curr Sports Med Rep"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB17|cit17","first-page":"522A","article-title":"Nonalcoholic fatty liver disease","volume":"48","author":"Schwingel","year":"2008","journal-title":"is androgen anabolic steroid a risk factor?"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00007256-200434080-00003","article-title":"Effects of androgenic-anabolic steroids in athletes","volume":"34","author":"Hartgens","year":"2004","journal-title":"Sports Med"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB19|cit19","first-page":"449","article-title":"Ultrastructural changes induced by anabolic steroids in liver of trained rats","volume":"8","author":"Gragera","year":"1993","journal-title":"Histol Histopathol"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB20|cit20","first-page":"34","article-title":"Anabolic steroid-induced hepatotoxicity","volume":"9","author":"Dickerman","year":"1999","journal-title":"is it overstated?"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB21|cit21","first-page":"391","article-title":"Evaluation of aminotransferase elevations in a bodybuilder using anabolic steroids","volume":"101","author":"Pertusi","year":"2001","journal-title":"hepatitis or rhabdomyolysis?"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB22|cit22","first-page":"486","article-title":"The effects of four weeks of ribose supplementation on body composition and exercise performance in healthy, young, male recreational bodybuilders","volume":"63","author":"Van Gammeren","year":"2002","journal-title":"a double-blind, placebo-controlled trial"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjcard.2005.10.026","article-title":"Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging","volume":"97","author":"Nottin","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men","volume":"335","author":"Bhasin","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1152\/jappl.1989.66.1.498","article-title":"Effect of testosterone on muscle mass and muscle protein synthesis","volume":"66","author":"Griggs","year":"1989","journal-title":"J Appl Physiol"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB26|cit26","first-page":"646","article-title":"Cholesterol transport in steroid biosynthesis","volume":"1791","author":"Rone","year":"2009","journal-title":"role of protein-protein interactions and implications in disease states"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.22063","article-title":"Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease","volume":"47","author":"Charlton","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0024-3205(01)00972-9","article-title":"Effect of androgenic anabolic steroids on sperm quality and serum hormone levels in adult male bodybuilders","volume":"68","author":"Torres-Calleja","year":"2001","journal-title":"Life Sci"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB29|cit29","first-page":"1103","article-title":"Nonalcoholic steatohepatitis","volume":"107","author":"Bacon","year":"1994","journal-title":"an expanded clinical entity"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am J Med"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB31|cit31","first-page":"173","article-title":"Interrelation between plasma testosterone and plasma insulin in healthy adult men","volume":"35","author":"Simon","year":"1992","journal-title":"the Telecom Study"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00004836-200210000-00013","article-title":"Androgenic\/anabolic steroid-induced toxic hepatitis","volume":"35","author":"Stimac","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1478-3231.2010.02346.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/15563650701590910","article-title":"Multivitamins and phospholipids complex protects the hepatic cells from androgenic-anabolic-steroids-induced toxicity","volume":"46","author":"Pagonis","year":"2008","journal-title":"Clin Toxicol"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2010.02346.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1478-3231.2010.02346.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T04:46:13Z","timestamp":1612673173000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1478-3231.2010.02346.x"}},"subtitle":["Anabolic steroids and TAFLD"],"short-title":[],"issued":{"date-parts":[[2010,10,11]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02346.x","relation":{},"ISSN":["1478-3223"],"issn-type":[{"value":"1478-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10,11]]}}}